Inventor · disambiguated record
Pavel Majer
Also filed as: MAJER PAVEL
29 granted patents·10 pending applications·140 citations·filing 1996–2024
95Inventor score
Files withUNIV JOHNS HOPKINS22GUILFORD PHARM INC7USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I3DRACEN PHARMACEUTICALS INC2MAJER PAVEL1
Top patents by PatentIndex Score
39 records- 0194US10738066B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Aug 11, 2020·5 cites·18 claims
- 0294US10336778B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2018·Granted Jul 2, 2019·8 cites·4 claims
- 0393US10954257B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Mar 23, 2021·4 cites·19 claims
- 0491US10842763B2Methods for cancer and immunotherapy using prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Nov 24, 2020·8 cites·16 claims
- 0591US9988407B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2015·Granted Jun 5, 2018·11 cites·11 claims
- 0689US11325931B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2020·Granted May 10, 2022·2 cites·19 claims
- 0789US6586623B2Thiol-based NAALADase inhibitorsGUILFORD PHARM INC·Filed 2002·Granted Jul 1, 2003·25 cites·25 claims
- 0883US11059775B2Prodrug compositions and utility of hydroxamate-based GCPII inhibitorsUNIV JOHNS HOPKINS·Filed 2017·Granted Jul 13, 2021·2 cites·1 claims
- 0980US10544176B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2018·Granted Jan 28, 2020·2 cites·4 claims
- 1078US12492160B2Prodrugs of itaconate and methyl itaconateUNIV JOHNS HOPKINS·Filed 2024·Granted Dec 9, 2025·0 cites·11 claims
- 1178US11932664B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2022·Granted Mar 19, 2024·0 cites·9 claims
- 1278US6812364B2Thiol-based NAALADase inhibitorsGUILFORD PHARM INC·Filed 2003·Granted Nov 2, 2004·8 cites·10 claims
- 1375US11926640B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2021·Granted Mar 12, 2024·0 cites·16 claims
- 1474US6458775B1NAALADase inhibitors useful as pharmaceutical compounds and compositionsGUILFORD PHARM INC·Filed 1999·Granted Oct 1, 2002·30 cites·55 claims
- 1573US11866394B2Prodrugs of hydroxamate-based GCPII inhibitorsUNIV JOHNS HOPKINS·Filed 2021·Granted Jan 9, 2024·0 cites·3 claims
- 1670US6884907B2Hydroxamic acids and acyl hydroxamines as naaladase inhibitorsGUILFORD PHARM INC·Filed 2002·Granted Apr 26, 2005·5 cites·18 claims
- 1766US11759444B2Methods for cancer and immunotherapy using prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2020·Granted Sep 19, 2023·0 cites·19 claims
- 1866US5849691APeptidomimetic inhibitors of cathepsin D and plasmepsins I and IIUS HEALTH·Filed 1996·Granted Dec 15, 1998·27 cites·10 claims
- 1965US11185534B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2018·Granted Nov 30, 2021·1 cites·4 claims
- 2063US7148250B2Indoles as NAALADase inhibitorsGUILFORD PHARM INC·Filed 2002·Granted Dec 12, 2006·2 cites·10 claims
- 2163US2023028516A1Prodrugs of itaconate and methyl itaconateUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 2260US6992215B2Thiol-based NAALADase inhibitorsGUILFORD PHARM INC·Filed 2004·Granted Jan 31, 2006·0 cites·10 claims
- 2358US2006135812A1Thiol-based NAALADase inhibitorsTSUKAMOTO TAKASHI·Filed 2006·Application pending·0 cites
- 2456US2024398962A1Dendrimer-glutamine antagonist conjugates and methods of use thereofUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2556US2024024347A1Prodrugs of 6-mercaptopurineUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2654US2024246902A1Prodrugs of 6-diazo-5-oxo-l-norleucineUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2753US10302632B2Macromolecular conjugates for visualization and separation of proteins and cellsUSTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I·Filed 2018·Granted May 28, 2019·0 cites·9 claims
- 2852US2023416294A1Decitabine analogs for immunological and oncological therapyUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2951US2023128984A1Bile acid-gcpii inhibitor conjugates to treat inflammatory diseases, including inflammatory bowel disease (ibd)UNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 3050US11712435B2Mebendazole prodrugs with enhanced solubility and oral bioavailabilityUNIV JOHNS HOPKINS·Filed 2019·Granted Aug 1, 2023·0 cites·19 claims
- 3147US2003083374A1NAALADase inhibitors useful as pharmaceutical compounds and compositionsFiled 2002·Application pending·0 cites
- 3247US2006009525A1Hydroxamic acids and acyl hydroxamines as NAALADase inhibitorsGUILFORD PHARM INC·Filed 2005·Application pending·0 cites
- 3346US12195419B2Glutamine antagonists and uses thereofUNIV JOHNS HOPKINS·Filed 2018·Granted Jan 14, 2025·0 cites·24 claims
- 3445US2018052152A1Macromolecular conjugates for visualization and separation of proteins and cellsUSTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I·Filed 2016·Application pending·0 cites
- 3538US10718772B2Method of detection of analyte active forms and determination of the ability of substances to bind into analyte active sitesUSTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR V V I·Filed 2015·Granted Jul 21, 2020·0 cites·60 claims
- 3636US12240797B2Method of preparing a DON prodrug from L-glutamic acidDRACEN PHARMACEUTICALS INC·Filed 2020·Granted Mar 4, 2025·0 cites·20 claims
- 3733US11760723B2Method of preparing a DON prodrug from L-pyroglutamic acidDRACEN PHARMACEUTICALS INC·Filed 2020·Granted Sep 19, 2023·0 cites·20 claims
- 3829US8703700B2Bimacrocylic HCV NS3 protease inhibitorsMAJER PAVEL·Filed 2010·Granted Apr 22, 2014·0 cites·20 claims
- 3928US10927146B2Peptidyl ketoamides as inhibitors of rhomboid proteasesUSTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I·Filed 2018·Granted Feb 23, 2021·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →